ES2042529T4 - Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa. - Google Patents

Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.

Info

Publication number
ES2042529T4
ES2042529T4 ES87117149T ES87117149T ES2042529T4 ES 2042529 T4 ES2042529 T4 ES 2042529T4 ES 87117149 T ES87117149 T ES 87117149T ES 87117149 T ES87117149 T ES 87117149T ES 2042529 T4 ES2042529 T4 ES 2042529T4
Authority
ES
Spain
Prior art keywords
preparing
removal
procedure
biologically active
free radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87117149T
Other languages
English (en)
Other versions
ES2042529T3 (es
Inventor
Robert Zimmermann
Benedict Joseph Marafino Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cetus Oncology Corp
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Application granted granted Critical
Publication of ES2042529T3 publication Critical patent/ES2042529T3/es
Publication of ES2042529T4 publication Critical patent/ES2042529T4/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES87117149T 1986-11-21 1987-11-20 Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa. Expired - Lifetime ES2042529T4 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93347586A 1986-11-21 1986-11-21
US11364387A 1987-10-26 1987-10-26

Publications (2)

Publication Number Publication Date
ES2042529T3 ES2042529T3 (es) 1993-12-16
ES2042529T4 true ES2042529T4 (es) 1996-07-16

Family

ID=26811304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87117149T Expired - Lifetime ES2042529T4 (es) 1986-11-21 1987-11-20 Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.

Country Status (5)

Country Link
EP (1) EP0269017B1 (es)
CA (1) CA1321349C (es)
DE (1) DE3780770T2 (es)
ES (1) ES2042529T4 (es)
GR (1) GR3005314T3 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5523077A (en) * 1992-02-06 1996-06-04 Yale University Composition and method for whitening skin
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
EP0688204B1 (en) * 1993-03-10 2001-05-30 Yale University Composition and cosmetic method for skin
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
WO1995024894A2 (en) * 1994-03-14 1995-09-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
FI3678739T3 (fi) 2017-09-07 2024-05-21 Childrens Hospital Philadelphia Koostumuksia ja menetelmiä periytyvän kystatiini c -amyloidiangiopatian (hccaa) ja muiden poikkeaviin amyloidikertymiin liittyvien hermostoa rappeuttavien häiriöiden hoitoon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526205A (en) * 1974-11-07 1978-09-27 Searle & Co Treatment of interferon-like material
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins

Also Published As

Publication number Publication date
DE3780770D1 (de) 1992-09-03
JPS63190831A (ja) 1988-08-08
GR3005314T3 (es) 1993-05-24
ES2042529T3 (es) 1993-12-16
EP0269017B1 (en) 1992-07-29
DE3780770T2 (de) 1993-02-25
EP0269017A2 (en) 1988-06-01
EP0269017A3 (en) 1989-06-21
CA1321349C (en) 1993-08-17

Similar Documents

Publication Publication Date Title
NO902156D0 (no) Terapeutisk anvendbar oxadiazolforbindelse og fremgangsmaate for dens fremstilling.
DE68920775T2 (de) Behandlung von faserigen Materialien.
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
DE3855489T2 (de) Behandlung von Hautfalten
ATA209789A (de) Behandlung von zementpulver
DK90089D0 (da) Hudbehandlingspraeparat
NO891823L (no) Overflatebehandling av haardt vev.
DE3580717D1 (de) Pharmazeutische anwendung von (nva)2-cyclosporine.
DE68909432T2 (de) Direkte Fixierung von geflochtenen Strukturen.
ES2042529T4 (es) Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
ES528497A0 (es) Procedimiento para la preparacion de una proteina hipocolesterolemicamente activa
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
DE69132054D1 (de) Behandlung von windelausschlag
DK141090A (da) Fremstilling af human prourokinase
DE69028631T2 (de) Behandlung von fasermaterialien
DK88790D0 (da) Terapeutisk virksomme midler
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
ES1000381Y (es) Calzado biolectromagnetico para uso terapeutico y general
NO871336D0 (no) Anvendelse av stoff som elektromagnetisk aktivt materiale.
ES551510A0 (es) Procedimiento para la fabricacion y acabado de cueros artificiales
BR6900065U (pt) Jogo para implante agulhado

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0269017

Country of ref document: ES